Nov 7, 2024 Medical Device Network: Castle Boasts Melanoma Test’s Capacity to Reduce Unnecessary Testing
Nov 6, 2024 The Dermatology Digest: Castle Biosciences’ DecisionDx-Melanoma Test Significantly Reduces Unnecessary SLNB Procedures
Oct 29, 2024 Houston Business Journal: Why Castle Biosciences Decided to Build New Headquarters in Friendswood
Oct 26, 2024 Dermatology Times: Innovative Insights in Skin Cancer Prognosis, Gene Expression Profiling, and Early Career Tips
